Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis
Open Access
- 1 January 2008
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (8) , 1257-1262
- https://doi.org/10.3748/wjg.14.1257
Abstract
Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysisKeywords
This publication has 30 references indexed in Scilit:
- Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classificationZeitschrift für Krebsforschung und Klinische Onkologie, 2007
- Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.2003
- Des–Gamma Carboxyprothrombin Can Differentiate Hepatocellular Carcinoma From Nonmalignant Chronic Liver Disease in American PatientsHepatology, 2003
- Current Status of the Molecular Characterization of the Ovarian Cancer Antigen CA125 and Implications for Its Use in Clinical ScreeningGynecologic Oncology, 2003
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSAUrologic Oncology: Seminars and Original Investigations, 2002
- Molecular pathogenesis of human hepatocellular carcinomaToxicology, 2002
- Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.2002
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Clinical Evaluation of Lentil Lectin-Reactive Alpha-Fetoprotein-L3 in Histology-Proven Hepatocellular CarcinomaThe International Journal of Biological Markers, 2001